The Federal Court of Australia has made a world-first ruling in favour of granting a patent to an artificial intelligence. But what comes next?
The decision is supported by the government’s policy environment in recent years. This has aimed to increase innovation, and views technology as a way to achieve this.
Stronger agricultural R&D systems will enable agriculture to power Africa’s transformation.
Boosting the number of female inventors isn’t just a matter of fairness. Inventions by men are more likely to ignore women’s needs.
Lowering the tax rates on profits from patents registered in Australia is unlikely to increase local research and development. But it will be a gift for multinationals.
Waiver talks might convince companies to focus on technology transfer and training, and let go of the plan to maximise patent-based revenues.
Much remains to be resolved before the waiver is translated into increased vaccine supply.
The process will take months, if it’s even approved. But just the threat of waiving intellectual property rights could spur faster action.
The US has backed a proposal to waive intellectual property relating to COVID measures – but global efforts need to go beyond vaccine patents.
The change in the US position signals how clearly the success of every country in fighting the pandemic depends on vaccinating the whole world.
It’s not clear whether the TRIPS agreement is what’s getting in the way of vaccine supply, and waiving intellectual property rights may stifle future innovation.
Too many patents and too little information about them makes it hard for the system to weed out patents that unfairly block inventors.
To continue the fast-paced collaborative research and innovation we have seen during the pandemic, here are five ways universities can support health research that responds to societal needs.
Plus new research on why China is closing down coal-fired power stations. Listen to episode 3 of The Conversation Weekly.
The story of invention in America typically features larger-than-life caricatures of white men like Thomas Edison while largely ignoring the contributions of women and people of color.
Most scientific discoveries these days aren’t easily ascribed to a single researcher. CRISPR is no different – and ongoing patent fights underscore how messy research can be.
A bioethicist explains a recent report that recommends how to distribute a COVID-19 vaccine equitably.
Many countries recruit overseas talent in science and technology, but China’s approach to gaining intellectual property is particularly aggressive.
Inventors in states with more socially liberal laws on the books end up with more diverse collaborators – and more higher-impact patents.
A unique challenge is emerging in the search for a COVID-19 vaccine: how to balance intellectual property rights with serving the public good.